{"product_id":"evotec-business-model-canvas","title":"Evotec Business Model Canvas","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eEvotec's Business Model: A Strategic Deep Dive\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eUnlock the strategic core of Evotec's innovative approach with our comprehensive Business Model Canvas. This detailed breakdown illuminates how Evotec effectively partners with clients, leverages its technological platforms, and generates revenue in the competitive drug discovery landscape. Discover the key resources and activities that drive their success and gain actionable insights for your own strategic planning.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eartnerships\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePharmaceutical Companies\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eEvotec's key partnerships with major pharmaceutical companies are foundational to its business model, driving innovation in drug discovery and development. These collaborations are strategic alliances designed to bring new therapies to market more efficiently.\u003c\/p\u003e\n\u003cp\u003eThese long-term agreements are crucial for advancing drug candidates from initial target identification through to clinical trials. Evotec's ability to co-create high-value pipelines makes it a sought-after partner for the world's leading pharmaceutical giants.\u003c\/p\u003e\n\u003cp\u003eIn 2024, Evotec continued to solidify its position by working with all of the Top 20 pharmaceutical companies, underscoring the breadth and depth of its industry relationships and its critical role in the global drug development ecosystem.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eBiotechnology Companies\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eEvotec actively collaborates with a diverse array of biotechnology firms, encompassing both emerging startups and larger, established entities. These partnerships are crucial for harnessing Evotec's advanced platforms and deep scientific knowledge to accelerate the progress of early-stage research and development, especially for innovative therapeutic candidates.\u003c\/p\u003e\n\u003cp\u003eThe company's commitment to advancing novel treatments is evident in its extensive network, providing essential solutions and expertise to more than 800 biotechnology companies worldwide. This broad reach underscores Evotec's role as a key enabler in the biotech ecosystem, facilitating the translation of groundbreaking ideas into potential medicines.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAcademic Institutions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eEvotec actively collaborates with universities and research centers to bridge the gap between scientific breakthroughs and drug development. These alliances are crucial for identifying novel drug targets and validating early-stage research.  In 2024, Evotec continued to foster these relationships, recognizing their importance in fueling its pipeline.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePatient Advocacy Groups\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eCollaborating with patient advocacy groups is crucial for Evotec, ensuring that their drug discovery initiatives directly address significant unmet medical needs and incorporate patient-centric viewpoints. These partnerships are vital for gaining deep insights into disease progression and understanding specific patient populations, which in turn helps in developing more effective therapeutic solutions.\u003c\/p\u003e\n\u003cp\u003eEvotec's commitment to these collaborations is evident in their recent strategic alliances. For instance, new agreements have been established with organizations such as the Crohn's \u0026amp; Colitis Foundation. Such partnerships are instrumental in refining research priorities and ensuring that the development pipeline remains focused on patient well-being and therapeutic impact.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e\n\u003cstrong\u003eAligning Discovery with Unmet Needs:\u003c\/strong\u003e Partnerships with groups like the Crohn's \u0026amp; Colitis Foundation ensure Evotec's drug discovery efforts are directly informed by patient experiences and critical unmet medical needs.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eGaining Patient Insights:\u003c\/strong\u003e These collaborations provide invaluable data on disease mechanisms and patient perspectives, guiding the development of more targeted and effective treatments.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStrategic Alliances:\u003c\/strong\u003e Evotec actively fosters new agreements with leading patient advocacy organizations to enhance the relevance and patient-centricity of its research programs.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTechnology \u0026amp; Platform Providers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eEvotec leverages partnerships with external technology and platform providers to augment its proprietary capabilities. These collaborations are crucial for integrating cutting-edge solutions, particularly in areas like AI-driven drug discovery and advanced manufacturing processes.\u003c\/p\u003e\n\u003cp\u003eFor instance, Evotec's strategic alliances extend to AI specialists, enabling the acceleration of target identification and validation. Furthermore, partnerships in advanced manufacturing, such as the expanded collaboration with Sandoz for biosimilars, highlight Evotec's commitment to enhancing production efficiency and expanding its service offerings in complex biologics.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e\n\u003cstrong\u003eAI Integration:\u003c\/strong\u003e Collaborations with AI firms to enhance data analysis and predictive modeling in drug discovery.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAdvanced Manufacturing:\u003c\/strong\u003e Partnerships for specialized manufacturing technologies, including those for biosimilars and complex biologics.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePlatform Enhancement:\u003c\/strong\u003e Joint ventures to develop and integrate new technological platforms, broadening Evotec's service portfolio.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSandoz Partnership:\u003c\/strong\u003e An example of a key alliance focused on the development and manufacturing of biosimilars, demonstrating a commitment to this growing market segment.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eEvotec's Collaborative Ecosystem for Drug Discovery\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eEvotec's key partnerships are a cornerstone of its innovation engine, fostering a collaborative ecosystem for drug discovery and development. These alliances are strategically cultivated to leverage specialized expertise and advance therapeutic pipelines efficiently.\u003c\/p\u003e\n\u003cp\u003eIn 2024, Evotec's extensive network included collaborations with all of the Top 20 pharmaceutical companies, alongside over 800 biotechnology firms globally. This broad reach is further strengthened by crucial academic partnerships aimed at identifying novel drug targets and validating early-stage research, ensuring a continuous flow of innovation.\u003c\/p\u003e\n\u003cp\u003eThe company also actively engages with patient advocacy groups, such as the Crohn's \u0026amp; Colitis Foundation, to ensure its research aligns with critical unmet medical needs and patient perspectives. Furthermore, strategic alliances with technology providers, including AI specialists and advanced manufacturing partners like Sandoz for biosimilars, augment Evotec's proprietary capabilities, driving efficiency and expanding its service offerings.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003ePartner Type\u003c\/th\u003e\n\u003cth\u003e2024 Focus\/Examples\u003c\/th\u003e\n\u003cth\u003eImpact\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eMajor Pharma\u003c\/td\u003e\n\u003ctd\u003eCollaborations with Top 20 Pharma\u003c\/td\u003e\n\u003ctd\u003eCo-creation of high-value pipelines, efficient drug development\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eBiotechnology Firms\u003c\/td\u003e\n\u003ctd\u003eOver 800 global biotech partners\u003c\/td\u003e\n\u003ctd\u003eAccelerating early-stage research, translating innovative ideas\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAcademic Institutions\u003c\/td\u003e\n\u003ctd\u003eBridging scientific breakthroughs and drug development\u003c\/td\u003e\n\u003ctd\u003eIdentifying novel drug targets, validating early research\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePatient Advocacy Groups\u003c\/td\u003e\n\u003ctd\u003eCrohn's \u0026amp; Colitis Foundation\u003c\/td\u003e\n\u003ctd\u003eAddressing unmet needs, incorporating patient-centric viewpoints\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTechnology\/Platform Providers\u003c\/td\u003e\n\u003ctd\u003eAI specialists, Sandoz (biosimilars)\u003c\/td\u003e\n\u003ctd\u003eAugmenting capabilities, enhancing manufacturing efficiency\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eA detailed Evotec Business Model Canvas outlining its drug discovery and development services, highlighting key partners, research platforms, and revenue streams.\u003c\/p\u003e\n\u003cp\u003eThis model emphasizes Evotec's integrated approach to drug discovery, from target identification to preclinical development, serving pharmaceutical and biotechnology clients.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eEvotec's Business Model Canvas acts as a pain point reliever by offering a structured, visual representation of their complex drug discovery and development operations, allowing for clearer identification of inefficiencies and opportunities.\u003c\/p\u003e\n\u003cp\u003eIt simplifies the intricate web of partnerships, research activities, and value propositions, enabling stakeholders to pinpoint and address bottlenecks in their innovation pipeline.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eA\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003ectivities\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDrug Discovery Research\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eEvotec's drug discovery research is a cornerstone of its business, focusing on identifying and validating new drug targets and then optimizing potential drug candidates. This intricate process involves deep scientific understanding and the use of Evotec's own advanced platforms.  In 2024, Evotec continued to emphasize this area, aiming to speed up the development of new medicines.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePreclinical Development Services\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eEvotec provides comprehensive preclinical development services, encompassing in vitro and in vivo studies, ADME-Tox assessments, and CMC development. These offerings are vital for progressing drug candidates from initial discovery through to the crucial stage of clinical trials.\u003c\/p\u003e\n\u003cp\u003eIn 2024, Evotec continued to highlight Drug Discovery \u0026amp; Pre-clinical Development as a foundational element of its business strategy, underscoring its commitment to supporting clients through these critical early-stage research phases.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eClinical Development Support\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eEvotec offers crucial support for clinical development, guiding partners through the intricate phases of human trials. Their comprehensive services, while strong in early-stage research, do extend to support clinical progression. This commitment is evidenced by their involvement in advancing over 100 proprietary and co-owned R\u0026amp;D projects into clinical development stages.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTechnology Platform Development\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eEvotec's core strength lies in its continuous investment and development of proprietary technology platforms. These include cutting-edge tools like Molecular Patient Databases, PanOmics, and iPSC-based disease models, all designed to significantly boost efficiency and success rates throughout the drug discovery and development pipeline.\u003c\/p\u003e\n\u003cp\u003eThe company is actively prioritizing automation, artificial intelligence (AI), and next-generation platforms to further enhance its capabilities. This strategic focus aims to accelerate the identification and validation of novel therapeutic targets and drug candidates.\u003c\/p\u003e\n\u003cp\u003eFor instance, Evotec's commitment to advanced platforms is evident in its ongoing efforts to integrate AI-driven insights into its research processes. By leveraging these technologies, Evotec aims to de-risk early-stage drug discovery, a critical factor in the pharmaceutical industry. In 2024, the company continued to expand its data infrastructure, supporting its AI initiatives with vast datasets. \u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e\n\u003cstrong\u003eProprietary Platform Development:\u003c\/strong\u003e Evotec actively develops and refines its unique technology platforms, crucial for efficient drug discovery.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAutomation and AI Integration:\u003c\/strong\u003e The company is heavily investing in automation and AI to streamline research and improve success rates.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eNext-Generation Platforms:\u003c\/strong\u003e Evotec is focused on building and utilizing advanced platforms that represent the future of drug development.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eData-Driven Research:\u003c\/strong\u003e Continuous expansion of data infrastructure supports AI-driven research, enhancing target identification and validation.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStrategic Alliance Management\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eEvotec's strategic alliance management is centered on cultivating enduring partnerships with key players in the pharmaceutical, biotechnology, and academic sectors. This involves meticulous oversight of ongoing collaborations, ensuring seamless project execution and mutual benefit from joint research and development endeavors.\u003c\/p\u003e\n\u003cp\u003eThe company's evolving strategy emphasizes the development of more profound, long-term alliances, particularly with major pharmaceutical corporations. This focus aims to leverage shared expertise and resources for accelerated drug discovery and development.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e\n\u003cstrong\u003eFostering Deep Partnerships:\u003c\/strong\u003e Evotec actively manages and nurtures its strategic alliances, ensuring they are mutually beneficial and contribute to shared research and development goals.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eLong-Term Collaboration Focus:\u003c\/strong\u003e The company's strategic direction prioritizes the establishment of deeper, long-term relationships with major pharmaceutical companies, moving beyond transactional collaborations.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eShared R\u0026amp;D Success:\u003c\/strong\u003e Effective management of these alliances is crucial for the success of shared research and development initiatives, driving innovation and bringing new therapies to market.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAccelerating Drug Discovery \u0026amp; Strategic Alliances in 2024\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eEvotec's key activities revolve around its advanced drug discovery and preclinical development services, leveraging proprietary technology platforms. The company also actively manages strategic alliances to foster long-term collaborations with leading pharmaceutical and biotech firms.  In 2024, Evotec continued to emphasize these core functions, aiming to accelerate the delivery of novel therapeutics.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eActivity\u003c\/th\u003e\n\u003cth\u003eDescription\u003c\/th\u003e\n\u003cth\u003e2024 Focus\/Data\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eDrug Discovery \u0026amp; Preclinical Development\u003c\/td\u003e\n\u003ctd\u003eIdentifying and optimizing drug candidates, preclinical studies, ADME-Tox, CMC development.\u003c\/td\u003e\n\u003ctd\u003eContinued emphasis on speeding up early-stage research; advancing over 100 proprietary and co-owned R\u0026amp;D projects.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eProprietary Platform Development\u003c\/td\u003e\n\u003ctd\u003eDeveloping and utilizing advanced technology platforms (e.g., AI, automation, iPSC models).\u003c\/td\u003e\n\u003ctd\u003eOngoing integration of AI-driven insights; expansion of data infrastructure to support AI initiatives.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eStrategic Alliance Management\u003c\/td\u003e\n\u003ctd\u003eBuilding and managing long-term partnerships with pharmaceutical, biotech, and academic entities.\u003c\/td\u003e\n\u003ctd\u003ePrioritizing deeper, long-term collaborations with major pharmaceutical companies for shared R\u0026amp;D success.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003ePreview Before You Purchase\u003c\/span\u003e\u003cbr\u003e Business Model Canvas\u003c\/h2\u003e\n\u003cp\u003eThe Evotec Business Model Canvas preview you are viewing is the actual document you will receive upon purchase. This means the structure, content, and formatting are identical to the final deliverable, ensuring no surprises. You can confidently assess the quality and completeness of the canvas before committing to your purchase. Upon completion of your order, you will gain full access to this comprehensive and ready-to-use Business Model Canvas.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"PESTEL Analysis","offers":[{"title":"Default Title","offer_id":55297689190748,"sku":"evotec-business-model-canvas","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0938\/8127\/0620\/files\/evotec-business-model-canvas.png?v=1755799222","url":"https:\/\/pestel-analysis.com\/products\/evotec-business-model-canvas","provider":"PESTEL ANALYSIS","version":"1.0","type":"link"}